U.S. Supreme Court Agrees To Hear South Carolina's Bid To End Public Funding Of Abortion Provider Planned Parenthood

BenzingaDec 19 00:11

Daré Bioscience Announces Phase 3 Plans For Sildenafil Cream, 3.6%, In The Treatment Of Female Sexual Arousal Disorder; Daré's Sildenafil Cream Has The Potential To Receive The First FDA Approval For FSAD

BenzingaDec 16 21:17

Daré Bioscience Announces Publication In Sexual Medicine Highlighting Positive Subgroup Findings From Phase 2b RESPOND Study Of Sildenafil Cream, 3.6%, For Female Sexual Arousal Disorder

BenzingaDec 10 21:07

Press Release: Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Dow JonesDec 4 21:00

Maxim Group Maintains Dare Bioscience(DARE.US) With Hold Rating

Futu NewsNov 16 23:32 · Ratings

Dare Bioscience Files to Sell 2.75M Shares of Common Stocks by Selling Shareholders

Seeking AlphaNov 16 06:32